Abstract:ABSTRACT Staphylococcus aureus produces various hemolysins regulated by the Agr-QS system, except β-hemolysin encoded by the gene hlb . A classical laboratory S. aureus strain RN4220 displays only the β-hemolysin phenotype. It was suspected that the 8A mutation at the end of its agrA gene delayed the expressions of hla and RNAIII , then failed to express α- and δ-hemolysins. However, hla gene expression was detected at the later culture time without α-hemolysin phenotype, the reason for such a phenotype has not been clearly understood. We created hlb knockout and complementary mutants via homologous recombination in RN4220 and NRS049, two strains that normally produce β-hemolysin and carry agrA mutation. We found interestingly that the presence or absence of α-hemolysin phenotype in such strains depended on the expression of β-hemolysin instead of agrA mutations, which only inhibited δ-hemolysin expression. The hemolysis phenotype was verified by the Christie-Atkinson-Munch-Peterson (CAMP) test. Quantitative reverse transcription PCR was carried out to evaluate the relative gene expressions of hlb , hla , and RNAIII . The construction of mutants did not affect the agrA mutation status. We demonstrate that the absence of α-hemolysin in S. aureus RN4220 and NRS049 strains is attributed to their production of β-hemolysin instead of agrA mutation. Our findings broaden the understanding of the molecular mechanisms that control hemolysin expression in S. aureus that is crucial for the development of new therapeutic strategies to combat S. aureus infections. IMPORTANCE α-Hemolysin is a critical virulence factor in Staphylococcus aureus and its expression is largely controlled by the Agr-QS system. Nonetheless, the hemolysis phenotype and the regulation of the Agr-QS system in S. aureus still hold many mysteries. Our study finds that it is the expression of β- hemolysin rather than the agrA mutation that inhibits the function of the α-hemolysin in an important S. aureus strain RN4220 and a clinical strain presents a similar phenotype, which clarifies the misunderstood hemolytic phenotype and mechanism of S. aureus . Our findings highlight the interactions among different toxins and their biological roles, combined with QS system regulation, which is ultimately the true underlying cause of its virulence. This emphasizes the importance of considering the collaborative action of various factors in the infection process caused by this significant human pathogen.

Alpha-Hemolysin from Staphylococcus Aureus Obstructs Yeast-Hyphae Switching and Diminishes Pathogenicity in Candida Albicans

Α-Hemolysin Suppresses Osteogenesis by Inducing Lipid Rafts Accumulation in Bone Marrow Stromal Cells

Lysine Inhibits Hemolytic Activity of Staphylococcus Aureus and Its Application in Food Model Contaminated with Staphylococcus Aureus.

Streptococcus Agalactiae Inhibits Candida Albicans Hyphal Development and Diminishes Host Vaginal Mucosal TH17 Response.

Staphylococcus Aureus Α-Hemolysin Mutant H35A Inhibit Cytotoxicity of Wild Α-Hemolysin

Reduction of histone proteins dosages increases CFW sensitivity and attenuates virulence of Candida albicans

Electron beam irradiation degrades the toxicity and alters the protein structure of Staphylococcus aureus alpha-hemolysin

Subinhibitory Concentrations of Prim-O-Glucosylcimifugin Decrease the Expression of Alpha-Hemolysin in Staphylococcus Aureus (USA300)

A Natural Dietary Flavone Myricetin as an α-Hemolysin Inhibitor for Controlling Staphylococcus aureus Infection

Inhibition of Fungal Pathogenicity by Targeting the H 2 S-synthesizing Enzyme Cystathionine Β-Synthase

<i>Staphylococcus aureus</i> Synergized with <i>Candida albicans</i> to Increase the Pathogenesis and Drug Resistance in Cutaneous Abscess and Peritonitis Murine Models

Subinhibitory Concentrations of Honokiol Reduce Α-Hemolysin (hla) Secretion by Staphylococcus Aureus and the Hla-induced Inflammatory Response by Inactivating the NLRP3 Inflammasome.

Diosmetin inhibits the expression of alpha-hemolysin in Staphylococcus aureus

Staphylococcus aureus Synergized with Candida albicans to Increase the Pathogenesis and Drug Resistance in Cutaneous Abscess and Peritonitis Murine Models

Candida albicans enhance Staphylococcus aureus virulence by progressive generation of new phenotypes

Baicalin Protects Mice from Staphylococcus Aureus Pneumonia Via Inhibition of the Cytolytic Activity of Α-Hemolysin

A peptidoglycan storm caused by β-lactam antibiotic’s action on host microbiota drives Candida albicans infection

Physical impediment to sodium houttuyfonate conversely reinforces β-glucan exposure stimulated innate immune response to Candida albicans

Preventing Candida Albicans from Subverting Host Plasminogen for Invasive Infection Treatment.

Baicalin protects mice from staphylococcus aureus pneumonia via inhibition of the cytolytic activity of-hemolysin

β-Hemolysin, not agrA mutation, inhibits the hemolysis of α-hemolysin in Staphylococcus aureus laboratory and clinical strains